Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA synthesis inhibition via ionizing radiation refers to the disruption or halting of DNA replication in cells exposed to ionizing radiation. This is primarily mediated by direct DNA damage (SSBs and DSBs) and indirect damage from ROS, triggering cell cycle checkpoints, DNA repair pathways, and ultimately cell death or senescence. This process is fundamental to the efficacy of radiotherapy in cancer treatment but also contributes to its toxicity. Variations in DNA repair capacity and checkpoint function influence individual radiosensitivity.
Ionizing radiation induces single-strand breaks (SSBs) and double-strand breaks (DSBs) in DNA, leading to replication fork stalling and activation of cell cycle checkpoints. Reactive oxygen species (ROS) contribute to DNA damage and further inhibit DNA synthesis.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibition of DNA Synthesis via Ionizing Radiation (IR-induced DNA Synthesis Inhibition).